293 related articles for article (PubMed ID: 15879867)
1. Clinical features and immunoexpression of p53, MIB-1 and proliferating cell nuclear antigen in adrenal neoplasms.
Martins AC; Cologna AJ; Tucci S; Suaid HJ; Falconi RA
J Urol; 2005 Jun; 173(6):2138-42. PubMed ID: 15879867
[TBL] [Abstract][Full Text] [Related]
2. Pathobiology of pituitary adenomas and carcinomas.
Scheithauer BW; Gaffey TA; Lloyd RV; Sebo TJ; Kovacs KT; Horvath E; Yapicier O; Young WF; Meyer FB; Kuroki T; Riehle DL; Laws ER
Neurosurgery; 2006 Aug; 59(2):341-53; discussion 341-53. PubMed ID: 16883174
[TBL] [Abstract][Full Text] [Related]
3. p53 and Ki-67 immunoreactivity and nuclear morphometry of 'carcinoma-in-adenoma' and adenoma of the gall-bladder.
Takei K; Watanabe H; Itoi T; Saito T
Pathol Int; 1996 Nov; 46(11):908-17. PubMed ID: 8970203
[TBL] [Abstract][Full Text] [Related]
4. Hyperadrenalism in childhood and adolescence.
Thomas CG; Smith AT; Griffith JM; Askin FB
Ann Surg; 1984 May; 199(5):538-48. PubMed ID: 6721603
[TBL] [Abstract][Full Text] [Related]
5. p53 and Ki-67 immunoreactivity and nuclear morphometry of 'carcinoma-in-adenoma' and adenoma of the gall-bladder.
Takei K; Watanabe H; Itoi T; Saito T
Pathol Int; 1996 Jun; 46(6):426-35. PubMed ID: 8869994
[TBL] [Abstract][Full Text] [Related]
6. Clinical tumor growth and comparison with proliferation markers in non-functioning (inactive) pituitary adenomas.
Saeger W; Lüdecke B; Lüdecke DK
Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):80-5. PubMed ID: 18072009
[TBL] [Abstract][Full Text] [Related]
7. Adrenocortical neoplasms: role of prognostic markers MIB-1, P53, and RB.
Vargas MP; Vargas HI; Kleiner DE; Merino MJ
Am J Surg Pathol; 1997 May; 21(5):556-62. PubMed ID: 9158680
[TBL] [Abstract][Full Text] [Related]
8. Biologic behavior of and p53 overexpression in multifocal renal cell carcinoma of clear cell type: an immunohistochemical study correlating grading, staging, and proliferation markers.
Haitel A; Wiener HG; Blaschitz U; Marberger M; Susani M
Cancer; 1999 Apr; 85(7):1593-8. PubMed ID: 10193951
[TBL] [Abstract][Full Text] [Related]
9. Comparison of proliferating cell nuclear antigen, thyroid transcription factor-1, Ki-67, p63, p53 and high-molecular weight cytokeratin expressions in papillary thyroid carcinoma, follicular carcinoma, and follicular adenoma.
Tan A; Etit D; Bayol U; Altinel D; Tan S
Ann Diagn Pathol; 2011 Apr; 15(2):108-16. PubMed ID: 21315633
[TBL] [Abstract][Full Text] [Related]
10. [Value of monoclonal antibodies (PC 10, MIB1, p53 and LeuM 1) for assessing the prognosis of patients with squamous epithelial carcinoma of the larynx after partial laser resection].
Hake R; Eckel H; von Pritzbuer E; Volling P; Thiele J
Pathologe; 1995 May; 16(3):197-203. PubMed ID: 7792271
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of endoscopic biopsy using immunostaining of p53 and Ki-67 in tumors of the ampulla of Vater.
Kubota K; Kakuta Y; Kawamura S; Saito S; Seki H; Kuniyoshi T
Pathol Int; 2003 Jun; 53(6):361-70. PubMed ID: 12787310
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical nuclear staining for p53, PCNA, and Ki-67 in different histologic variants of basal cell carcinoma.
Barrett TL; Smith KJ; Hodge JJ; Butler R; Hall FW; Skelton HG
J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):430-7. PubMed ID: 9308559
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis control and proliferation marker in human normal and neoplastic adrenocortical tissues.
Bernini GP; Moretti A; Viacava P; Bonadio AG; Iacconi P; Miccoli P; Salvetti A
Br J Cancer; 2002 May; 86(10):1561-5. PubMed ID: 12085205
[TBL] [Abstract][Full Text] [Related]
14. p53 protein, PCNA staining, and DNA content in follicular neoplasms of the thyroid gland.
Czyz W; Joensuu H; Pylkkänen L; Klemi PJ
J Pathol; 1994 Dec; 174(4):267-74. PubMed ID: 7884588
[TBL] [Abstract][Full Text] [Related]
15. Adrenocortical tumors in children.
Ciftci AO; Senocak ME; Tanyel FC; Büyükpamukçu N
J Pediatr Surg; 2001 Apr; 36(4):549-54. PubMed ID: 11283875
[TBL] [Abstract][Full Text] [Related]
16. [Cyclo-oxygenase-2 and p53 immunoreactivity in superficial early colorectal carcinoma].
Kim YS; Lim SD; Lee JK; Kim SE; Ryu SH; Lee JW; Moon JS
Korean J Gastroenterol; 2006 May; 47(5):350-6. PubMed ID: 16714876
[TBL] [Abstract][Full Text] [Related]
17. Preoperatively irradiated rectal carcinoma: analysis of the histopathologic response and predictive value of proliferating cell nuclear antigen immunostaining.
Díez M; Ramos P; Medrano MJ; Mugüerza JM; Villeta R; Lozano O; Escribano J; Noguerales F; Ruíz A; Granell J
Oncology; 2003; 64(3):213-9. PubMed ID: 12697960
[TBL] [Abstract][Full Text] [Related]
18. Expression of p53 and selected proliferative markers (Ki-67, MCM3, PCNA, and topoisomerase IIα) in borderline ovarian tumors: Correlation with clinicopathological features.
Ciepliński K; Jóźwik M; Semczuk-Sikora A; Gogacz M; Lewkowicz D; Ignatov A; Semczuk A
Histol Histopathol; 2018 Feb; 33(2):171-179. PubMed ID: 28493257
[TBL] [Abstract][Full Text] [Related]
19. Giant pituitary adenomas: pathologic-radiographic correlations and lack of role for p53 and MIB-1 labeling.
Madsen H; Borges TM; Knox AJ; Michaelis KA; Xu M; Lillehei KO; Wierman ME; Kleinschmidt-DeMasters BK
Am J Surg Pathol; 2011 Aug; 35(8):1204-13. PubMed ID: 21753697
[TBL] [Abstract][Full Text] [Related]
20. The role of immunohistochemistry in histopathological diagnostics of clinically "silent" incidentally detected adrenal masses.
Babinska A; Sworczak K; Wisniewski P; Nałecz A; Jaskiewicz K
Exp Clin Endocrinol Diabetes; 2008 Apr; 116(4):246-51. PubMed ID: 18393131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
